Talis Biomedical Corporation (NASDAQ:TLIS) Investor Notice: Lawsuit Alleges Securities Laws Violations
January 27, 2022 at 12:45 PM EST
San Diego, CA -- (SBWIRE) -- 01/27/2022 -- An investor, who purchased shares of Talis Biomedical Corporation (NASDAQ:TLIS), filed a lawsuit over alleged violations of Federal Securities Laws by Talis Biomedical Corporation in connection with the Company's February 2021 initial public offering ("IPO").
